4//SEC Filing
Klausner Mark R. 4
Accession 0001140361-21-008348
CIK 0001586049other
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 4:36 PM ET
Size
15.4 KB
Accession
0001140361-21-008348
Insider Transaction Report
Form 4
Klausner Mark R.
Director
Transactions
- Disposition to Issuer
Ordinary Shares
2021-03-08$22.00/sh−4,081$89,782→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$11.07/sh−3,728$41,269→ 0 totalExercise: $10.93Exp: 2028-03-01→ Ordinary Shares (3,728 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.51/sh−7,457$56,002→ 0 totalExercise: $14.49Exp: 2028-06-19→ Ordinary Shares (7,457 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.56/sh−7,457$56,375→ 0 totalExercise: $14.44Exp: 2029-06-18→ Ordinary Shares (7,457 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$11.07/sh−14,914$165,098→ 0 totalExercise: $10.93Exp: 2028-03-01→ Ordinary Shares (14,914 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$9.04/sh−9,494$85,826→ 0 totalExercise: $12.96Exp: 2030-06-24→ Ordinary Shares (9,494 underlying)
Footnotes (3)
- [F1]Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
- [F2]In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
- [F3]Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001732629
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 7:00 PM ET
- Accepted
- Mar 12, 4:36 PM ET
- Size
- 15.4 KB